Filing Details
- Accession Number:
- 0001209191-17-046026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 20:02:26
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 20:02:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610876 | Jeffrey Chodakewitz | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp Gmda, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-19 | 6,303 | $96.87 | 128,814 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 32,343 | $109.14 | 161,157 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-19 | 39,833 | $161.00 | 121,324 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 700 | $158.08 | 120,624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 1,000 | $158.92 | 119,624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 400 | $159.85 | 119,224 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 3,464 | $161.38 | 115,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 1,336 | $162.04 | 114,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 6,303 | $0.00 | 6,303 | $96.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 32,343 | $0.00 | 32,343 | $109.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,875 | 2024-07-14 | No | 4 | M | Direct | |
| 25,157 | 2025-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $158.08 (range $157.48 to $158.41).
- Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $158.92 (range $158.61 to $159.48).
- Open market sales reported on this line occurred at a weighted average price of $159.85 (range $159.64 to $160.25).
- Open market sales reported on this line occurred at a weighted average price of $161.38 (range $160.90 to $161.89).
- Open market sales reported on this line occurred at a weighted average price of $162.04 (range $161.90 to $162.38).
- The option vests in 16 quarterly installments from 7/15/2014.
- The option vests in 16 quarterly installments from 2/3/2015.
Billionaire Hedge Funds
